These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10987087)

  • 1. HIV RNA packaging and lentivirus-based vectors.
    Lever AM
    Adv Pharmacol; 2000; 48():1-28. PubMed ID: 10987087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.
    Arya SK; Zamani M; Kundra P
    Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance.
    Sachdeva G; D'Costa J; Cho JE; Kachapati K; Choudhry V; Arya SK
    J Med Virol; 2007 Feb; 79(2):118-26. PubMed ID: 17177309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors.
    Poeschla E; Gilbert J; Li X; Huang S; Ho A; Wong-Staal F
    J Virol; 1998 Aug; 72(8):6527-36. PubMed ID: 9658096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.
    Kaye JF; Lever AM
    J Virol; 1998 Jul; 72(7):5877-85. PubMed ID: 9621049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage.
    Strappe PM; Hampton DW; Brown D; Cachon-Gonzalez B; Caldwell M; Fawcett JW; Lever AM
    Retrovirology; 2005 Sep; 2():55. PubMed ID: 16168051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.
    Laham-Karam N; Bacharach E
    J Virol; 2007 Oct; 81(19):10687-98. PubMed ID: 17652403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genome packaging and Gag translation/AUG of primate lentiviruses.
    Sakuragi S; Shioda T; Sakuragi JI
    Microbes Infect; 2019 Mar; 21(2):119-123. PubMed ID: 30292880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.
    Gu S; Ji J; Kim JD; Yee JK; Rossi JJ
    Oligonucleotides; 2006; 16(4):287-95. PubMed ID: 17155905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic determination of the packaging limit of lentiviral vectors.
    Kumar M; Keller B; Makalou N; Sutton RE
    Hum Gene Ther; 2001 Oct; 12(15):1893-905. PubMed ID: 11589831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper virus-free transfer of human immunodeficiency virus type 1 vectors.
    Richardson JH; Kaye JF; Child LA; Lever AM
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():691-6. PubMed ID: 7897357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.
    Russell RS; Hu J; Bériault V; Mouland AJ; Laughrea M; Kleiman L; Wainberg MA; Liang C
    J Virol; 2003 Jan; 77(1):84-96. PubMed ID: 12477813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of genome dimerization from packaging functions and virion maturation of human immunodeficiency virus type 1.
    Sakuragi J; Iwamoto A; Shioda T
    J Virol; 2002 Feb; 76(3):959-67. PubMed ID: 11773371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction of cell lines and primary cells by FIV-packaged HIV vectors.
    Morris KV; Gilbert J; Wong-Staal F; Gasmi M; Looney DJ
    Mol Ther; 2004 Jul; 10(1):181-90. PubMed ID: 15272479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation.
    Lanchy JM; Lodmell JS
    J Virol; 2007 Apr; 81(7):3285-92. PubMed ID: 17229705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus vectors for gene therapy.
    Lever AM; Kaye JF; McCann E; Chadwick D; Dorman N; Thomas J; Zhao J
    Biochem Soc Trans; 1999 Dec; 27(6):841-7. PubMed ID: 10830114
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5' regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal.
    Berkowitz RD; Hammarskjöld ML; Helga-Maria C; Rekosh D; Goff SP
    Virology; 1995 Oct; 212(2):718-23. PubMed ID: 7571442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.